| Literature DB >> 24631823 |
A Gonçalves1, P Poeta2, R Monteiro1, C Marinho1, N Silva3, A Guerra4, F Petrucci-Fonseca4, J Rodrigues2, C Torres5, R Vitorino6, P Domingues6, G Igrejas7.
Abstract
The Iberian wolf (Canis lupus signatus) is an endangered species native to the Iberian Peninsula. Due to their predatory and wild nature, these wolves serve as important indicators of environmental contamination by antimicrobial-resistant bacteria. β-Lactam antibiotics like cefotaxime are the most commonly used antibacterial agents. Bacterial resistance to these antibiotics occurs predominantly through enzymatic inactivation by extended-spectrum beta-lactamases. Escherichia coli strain WA57, isolated from Iberian wolf feces, is a cefotaxime-resistant strain that produces extended-spectrum beta-lactamases. In this study, using 2D-GE combined with MS and bioinformatics, we report significant differences in the abundance of 40 protein spots (p<0.01) from the extracellular, periplasmic, cytoplasmic, and membrane sub-proteomes and the whole-cell proteome of WA57 exposed and non-exposed to cefotaxime. A total of 315 protein spots were collected for protein identification. The comparative proteomics presented gives an overview of the complex changes in expression and metabolism that occur when WA57 is stressed with cefotaxime. Abundance of chaperone, porin and export proteins is particularly affected showing that the stress response and transport functions might directly influence the antibiotic resistance of this strain. BIOLOGICAL SIGNIFICANCE: This study highlights the importance of proteomics in detecting protein expression changes in bacterial strains exposed to stress such as that caused by cefotaxime. This approach might help us understand which pathways form barriers for antibiotics. This article is part of a Special Issue entitled: Environmental and structural proteomics.Entities:
Keywords: Antibiotic resistance; Escherichia coli; Iberian wolf; Mass spectrometry; Subcellular proteomes
Mesh:
Substances:
Year: 2014 PMID: 24631823 DOI: 10.1016/j.jprot.2014.02.033
Source DB: PubMed Journal: J Proteomics ISSN: 1874-3919 Impact factor: 4.044